Puberty blockers, child consent and gender-affirming care raise urgent safeguarding questions. Are children equipped to make life-altering medical decisions?
There are few areas of medicine where caution should matter more than when the patient is a child.
Yet the debate surrounding puberty blockers, gender-affirming hormones and children has become so politically charged that asking basic questions about consent, evidence and safeguarding can quickly be interpreted as an attack on transgender people.
It shouldn't be.
Children experiencing gender dysphoria deserve compassion. They deserve to be listened to. They deserve psychological and medical care that treats them with dignity.
But children also deserve adults who are prepared to ask whether an intervention that may affect their developing body, fertility, sexual development and future medical pathway should be undertaken before they have reached adulthood.
For me, this is fundamentally a child-safeguarding question.
And I believe we should be able to ask it.
Children are not miniature adults
Australian law recognises that some children may have sufficient maturity to consent to particular medical treatments under what is commonly known as Gillick competence.
Capacity isn't determined simply by turning a particular age. It requires consideration of whether the young person sufficiently understands the proposed treatment, its nature, risks, potential consequences and alternatives. Where a child isn't capable of providing their own informed consent, a parent or legal guardian may generally consent on their behalf.
That legal framework exists for good reason.
But legality doesn't remove the ethical question.
A child may be capable of understanding that a treatment involves injections, that their body may change or that they desperately want their distress to stop.
That is different from being able to comprehend what those decisions might mean to them at 25, 35 or 45.
Children and adolescents are still developing emotionally, cognitively and socially. Their understanding of themselves can develop too.
That doesn't mean their feelings aren't real.
It means adults carry an enormous responsibility when responding to them.
The evidence itself is still being examined
This is where the argument that children can simply provide "informed consent" becomes particularly difficult for me.
How completely can a young person understand the long-term implications of a treatment when the medical evidence itself continues to be reviewed?
Queensland commissioned an independent expert review of puberty suppression and gender-affirming hormone treatment for people under 18. Its report, released in December 2025, found a near-consensus among international reviews that the evidence underlying the use of puberty blockers and gender-affirming hormones for young people with gender dysphoria is limited, citing methodological limitations including short-term and observational studies.
Queensland currently restricts new patients under 18 in its public hospital system from commencing puberty blockers or gender-affirming hormones for gender dysphoria, while existing patients may continue treatment where clinically indicated.
Australia's National Health and Medical Research Council is also developing new national clinical practice guidelines for the care of trans and gender-diverse people under 18 with gender dysphoria.
Puberty suppression has been specifically prioritised.
As of September 2026, the evidence reviews are continuing, interim advice on puberty suppression is expected to go to public consultation later in 2026, and the complete national guidelines aren't expected until 2028.
That doesn't prove these treatments are inherently harmful.
But neither does it justify shutting down questions about them.
It tells us that this is a complex and evolving field of medicine in which significant questions remain.
When children are involved, uncertainty should increase caution — not reduce it.
Supporting a child is not the same as medicalising a child
There is another distinction this debate desperately needs.
A preschool-aged child attending a gender service is not necessarily receiving puberty blockers or hormones.
Major endocrine guidance recommends against puberty-blocking or gender-affirming hormone treatment in prepubertal children. It instead emphasises appropriately trained professionals, psychological assessment and support. Medical intervention is considered later, after puberty has begun and subject to assessment.
That matters because inaccurate claims weaken legitimate safeguarding concerns.
My objection isn't to a child being listened to.
It isn't to counselling.
It isn't to allowing a child to explore how they feel.
And it certainly isn't an argument that transgender adults don't exist or don't deserve dignity and respect.
My concern begins when adults move from listening to a developing child to medically altering that child's developing body.
Those are not the same thing.
Who carries responsibility?
Children cannot be expected to protect themselves from every consequence of decisions made during childhood.
That is why childhood safeguarding exists.
Adults carry responsibility.
Parents carry it.
Doctors carry it.
Hospitals carry it.
Professional bodies carry it.
Governments carry it.
Children's Health Queensland itself acknowledged in July 2026 that treatment should focus on the best available research and the child's best interests rather than directing children down a predetermined treatment pathway. It said clinicians should take a holistic approach and consider mental-health conditions, comorbidities and other relevant factors before determining treatment.
That principle should be uncontroversial.
A child who expresses distress about their sex or body should never automatically be told what that distress means.
They deserve exploration, not predetermined conclusions.
They deserve time.
They deserve comprehensive assessment.
They deserve adults willing to tolerate uncertainty.
And they deserve the opportunity to grow without feeling that questioning an earlier understanding of themselves represents failure.
When does treatment become harm?
This is where my position becomes uncomfortable for some people.
I have come to believe that there are circumstances in which medically transitioning a child can cross the line from healthcare into harm - and, in my view, potentially amount to a form of child abuse.
I don't use those words lightly.
Nor am I claiming that doctors treating gender dysphoria deliberately set out to harm children. Many clinicians and parents undoubtedly believe they are alleviating genuine distress and acting in the child's best interests.
Intent, however, is not the only measure by which harm should be assessed.
History contains many examples of treatments performed with good intentions that medicine later reconsidered when evidence changed.
Safeguarding requires us to consider outcomes, vulnerability, power and capacity — not simply motivation.
When an adult authorises an intervention affecting a child's healthy developing body, the standard of evidence and consent should be extraordinarily high.
And when the evidence is uncertain, the consequences potentially extend into adulthood, and the patient is still developing, I believe the precautionary principle must matter.
Compassion and caution can coexist
There is a tendency in this debate to demand allegiance to one of two extremes.
Either unquestionably affirm every expressed gender identity and pathway, or deny the experiences of transgender and gender-diverse young people altogether.
I reject that choice.
A child can be experiencing profound gender dysphoria and still require adults to exercise caution.
A child can deserve affirmation of their dignity without every medical intervention being affirmed.
A child can be listened to without being expected to make adult decisions.
And questioning paediatric gender medicine does not require hostility towards transgender people.
In fact, genuine compassion should make us willing to examine difficult evidence and uncomfortable questions.
Children deserve healthcare based on rigorous evidence rather than political pressure from either direction.
They deserve clinicians who are free to question prevailing practice.
They deserve parents who receive complete information about benefits, uncertainties, alternatives and potential long-term consequences.
Most of all, they deserve time to become the adults who will ultimately live in their bodies.
Safeguarding must come first
My position isn't that children experiencing gender dysphoria should be abandoned.
It is almost the opposite.
They should receive more support, not less.
Comprehensive psychological care. Family support. Careful assessment. Protection from bullying and discrimination. Space to explore identity without pressure to arrive at a predetermined destination.
But when treatment moves into medically changing a child's developing body, we must be willing to apply a much higher threshold.
The question isn't whether a child's feelings matter.
They do.
The question is whether feeling certain about something as a child is enough to justify medical decisions whose consequences may reach far beyond childhood.
For me, the responsibility remains with the adults.
Children deserve compassion, support and the freedom to explore who they are.
But compassion does not require us to abandon caution.
And affirmation must never remove our responsibility to safeguard a child's body, development and future.
When medicine itself is still examining the evidence, protecting children must come before protecting any ideology.
Sources to follow:
- Queensland Health — Independent Review of Stage 1 and Stage 2 Hormone Therapies (2025). This is particularly valuable because it is Australian, independent and directly relevant to the Queensland controversy that prompted the article. The review examined puberty suppression and gender-affirming hormones and identified limitations in the evidence base.
Queensland Health independent hormone therapies review - NHMRC — National clinical practice guidelines for under-18 gender dysphoria care. This is one of your strongest Australian links. The NHMRC is currently undertaking its own rigorous evidence review, has specifically prioritised puberty suppression, and says interim advice will be released for consultation in late 2026. That demonstrates that Australia's national evidence and guidance are still being actively examined.
NHMRC national gender guidelines project - Taylor et al., 2024 — Systematic review of puberty suppression, Archives of Disease in Childhood. This is probably the single strongest academic citation for your article. The researchers reviewed 50 studies and concluded there was a lack of high-quality research. They found limited or inconsistent evidence concerning psychological and psychosocial outcomes, cognition and fertility, and reported that bone health and height may be compromised during treatment.
Read the puberty suppression systematic review on PubMed - Taylor et al., 2024 — Systematic review of masculinising and feminising hormones in adolescents. This companion systematic review found a lack of high-quality research on hormone treatment. Importantly, it also found some moderate-quality evidence suggesting short-term improvements in psychological health, so citing it shows that you aren't cherry-picking only findings favourable to your position. For several other outcomes, the researchers said conclusions could not yet be drawn.
Read the hormone-treatment systematic review - NHS England — Puberty suppressing hormone clinical policy. Since March 2024, puberty blockers have not been routinely commissioned by NHS England for children and young people with gender incongruence or gender dysphoria. NHS England explicitly refers to the limited evidence concerning safety, risks, benefits and outcomes.
NHS England puberty suppressing hormones policy - NHS England — implementation of the Cass Review. The Cass Review was a four-year independent review of children's gender identity services. NHS England subsequently moved towards a more holistic model of care and stopped routine prescribing of puberty blockers.
NHS England implementation of the Cass Review
There is also a particularly useful UK Government summary of the evidence behind its puberty-blocker policy. It notes that the Cass Review identified weak evidence regarding effects on gender dysphoria-related distress and mental or psychosocial health, compromised bone density during suppression, and uncertainty around cognitive and psychosexual development.
UK Government evidence assessment on puberty blockers
#PubertyBlockers, #ChildConsent, #ChildSafeguarding, #ChildProtection, #ChildrensRights, #GenderAffirmingCare, #GenderDysphoria, #MedicalEthics, #InformedConsent, #ProtectChildren, #SafetyFromViolence, #RoseDavidson
